Effects of secukinumab on bone mineral density and bone turnover biomarkers in patients with ankylosing spondylitis: 2-year data from a phase 3 study, MEASURE 1

BACKGROUND: Axial spondyloarthritis including ankylosing spondylitis (AS) is characterized by chronic inflammation and new bone formation in the axial skeleton. On the other hand, bone loss, osteoporosis and an increased risk of vertebral fractures is known to frequently occur in AS. In the MEASURE...

Descripción completa

Detalles Bibliográficos
Autores principales: Braun, Jürgen, Buehring, Bjoern, Baraliakos, Xenofon, Gensler, Lianne S., Porter, Brian, Quebe-Fehling, Erhard, Haemmerle, Sibylle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670267/
https://www.ncbi.nlm.nih.gov/pubmed/34903218
http://dx.doi.org/10.1186/s12891-021-04930-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670267/
https://www.ncbi.nlm.nih.gov/pubmed/34903218
http://dx.doi.org/10.1186/s12891-021-04930-1

Ejemplares similares